RavenQuest BioMed Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
RVVQF has 182.13 million shares outstanding.
| Current Share Class | 182.13M |
| Shares Outstanding | 182.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.49, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.49 |
| Quick Ratio | 0.30 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.82 |
| Interest Coverage | -4.34 |
Financial Efficiency
Return on equity (ROE) is -112.46% and return on invested capital (ROIC) is -20.32%.
| Return on Equity (ROE) | -112.46% |
| Return on Assets (ROA) | -18.85% |
| Return on Invested Capital (ROIC) | -20.32% |
| Return on Capital Employed (ROCE) | -40.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -139.08 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 45.87 |
| Average Volume (20 Days) | 10,113 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 63.48 |
Income Statement
In the last 12 months, RVVQF had revenue of 1.16 million and -24.61 million in losses. Loss per share was -0.22.
| Revenue | 1.16M |
| Gross Profit | 678,943 |
| Operating Income | -10.49M |
| Pretax Income | -25.05M |
| Net Income | -24.61M |
| EBITDA | -7.53M |
| EBIT | -10.49M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 569,962 in cash and 11.25 million in debt, giving a net cash position of -10.68 million or -0.06 per share.
| Cash & Cash Equivalents | 569,962 |
| Total Debt | 11.25M |
| Net Cash | -10.68M |
| Net Cash Per Share | -0.06 |
| Equity (Book Value) | 15.62M |
| Book Value Per Share | 0.13 |
| Working Capital | -2.19M |
Cash Flow
In the last 12 months, operating cash flow was -711,245 and capital expenditures -5.46 million, giving a free cash flow of -6.17 million.
| Operating Cash Flow | -711,245 |
| Capital Expenditures | -5.46M |
| Free Cash Flow | -6.17M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | 58.63% |
| Operating Margin | -906.08% |
| Pretax Margin | -2,163.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RVVQF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.47% |
| Shareholder Yield | -53.47% |
| Earnings Yield | -13,523,337.36% |
| FCF Yield | -3,389,962.64% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RVVQF has an Altman Z-Score of -0.54. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.54 |
| Piotroski F-Score | n/a |